The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-(pyridin-3-yl)benzamide ID: ALA4522631
Cas Number: 1138239-36-7
PubChem CID: 57428036
Max Phase: Preclinical
Molecular Formula: C12H10N2O
Molecular Weight: 198.22
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: NC(=O)c1ccc(-c2cccnc2)cc1
Standard InChI: InChI=1S/C12H10N2O/c13-12(15)10-5-3-9(4-6-10)11-2-1-7-14-8-11/h1-8H,(H2,13,15)
Standard InChI Key: HRWJRXNTRLZCAI-UHFFFAOYSA-N
Molfile:
RDKit 2D
15 16 0 0 0 0 0 0 0 0999 V2000
12.7187 -17.9410 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7176 -18.7606 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4256 -19.1695 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.1353 -18.7601 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1324 -17.9374 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4238 -17.5322 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0130 -17.5328 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0141 -16.7145 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3071 -16.3061 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5985 -16.7149 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6014 -17.5364 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3089 -17.9410 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8902 -16.3075 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1831 -16.7172 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.8889 -15.4903 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 7 1 0
1 7 1 0
10 13 1 0
13 14 2 0
13 15 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 198.22Molecular Weight (Monoisotopic): 198.0793AlogP: 1.85#Rotatable Bonds: 2Polar Surface Area: 55.98Molecular Species: NEUTRALHBA: 2HBD: 1#RO5 Violations: ┄HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 4.70CX LogP: 1.25CX LogD: 1.25Aromatic Rings: 2Heavy Atoms: 15QED Weighted: 0.80Np Likeness Score: -1.22
References 1. Kwiatkowski J, Liu B, Pang S, Ahmad NHB, Wang G, Poulsen A, Yang H, Poh YR, Tee DHY, Ong E, Retna P, Dinie N, Kwek P, Wee JLK, Manoharan V, Low CB, Seah PG, Pendharkar V, Sangthongpitag K, Joy J, Baburajendran N, Jansson AE, Nacro K, Hill J, Keller TH, Hung AW.. (2020) Stepwise Evolution of Fragment Hits against MAPK Interacting Kinases 1 and 2., 63 (2): [PMID:31910010 ] [10.1021/acs.jmedchem.9b01582 ]